Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
6 pending office actions • 5 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready
Vos-IP, LLC operates in the Biotechnology & Pharmaceuticals technology area with 328 career applications. The firm has a resolved allowance rate of 82.09 percent. Prosecution involves an average of 3.42 office actions per allowance. These statistics provide a baseline for understanding the firm's historical performance in its primary field of practice and its success in securing patent protections.
There are 5 pending office actions currently being handled by the firm. The 82.09 percent allowance rate and 3.42 average office actions per allowance define the firm's historical performance across 328 career applications. These figures provide a baseline for clients in the Biotechnology & Pharmaceuticals sector. This data is essential for evaluating the firm's experience and the expected procedural requirements for new patent applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCPHERSON, JAMES M | 1 | 82.3% | +17.2% |
| STEINKE, SEAN JAMES | 1 | 11.8% | +43.3% |
| GINGRICH, SHADAN HAGHANI | 1 | 61.8% | +17.2% |
| PACHECO, ALEXIS BOATENG | 1 | 77.7% | +12.9% |
| VASUDEVA, AJAY | 1 | 70.8% | +22.7% |
| BREEN, KIMBERLY CATHERINE | 1 | 23.8% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19225100 | SENSOR FUSION-BASED EARLY WARNING SYSTEM | MCPHERSON, JAMES M | — |
| 18853465 | STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ERDAFITINIB | STEINKE, SEAN JAMES | — |
| 18538683 | ELECTRICAL CHARGING STORAGE DEVICE | PACHECO, ALEXIS BOATENG | — |
| 18562952 | AN UNDERWATER PROBE OR SUBMERSIBLE | VASUDEVA, AJAY | — |
| 18248392 | COLLAGEN BIOMATERIAL | BREEN, KIMBERLY CATHERINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18850133 | VISUAL ANALYZER OF CONFINED PATHWAYS | GINGRICH, SHADAN HAGHANI | 40d |
| 19225100 | SENSOR FUSION-BASED EARLY WARNING SYSTEM | MCPHERSON, JAMES M | — |
| 18853465 | STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ERDAFITINIB | STEINKE, SEAN JAMES | — |
| 18538683 | ELECTRICAL CHARGING STORAGE DEVICE | PACHECO, ALEXIS BOATENG | — |
| 18562952 | AN UNDERWATER PROBE OR SUBMERSIBLE | VASUDEVA, AJAY | — |
| 18248392 | COLLAGEN BIOMATERIAL | BREEN, KIMBERLY CATHERINE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| UAM Tec Pty Ltd | 2 |
| J Humble & A Muthiah | 1 |
| NATCO PHARMA LIMITED | 1 |
| Ampicity, Inc. | 1 |
| Hide Biotech Ltd. | 1 |
| Art Unit | Apps |
|---|---|
| 3663 | 1 |
| 1619 | 1 |
| 2485 | 1 |
| 2859 | 1 |
| 3615 | 1 |
| 1657 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19225100 | SENSOR FUSION-BASED EARLY WARNING SYSTEM | J Humble & A Muthiah | MCPHERSON, JAMES M | 3663 | §102§103 | Non-Final OA | — | Pending | Jun 02, 2025 |
| 18853465 | STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ERDAFITINIB | Natco Pharma Limited | STEINKE, SEAN JAMES | 1619 | §103§112 | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18850133 | VISUAL ANALYZER OF CONFINED PATHWAYS | UAM Tec Pty Ltd | GINGRICH, SHADAN HAGHANI | 2485 | §103 | Final Rejection | 40d | Pending | Sep 24, 2024 |
| 18538683 | ELECTRICAL CHARGING STORAGE DEVICE | Ampicity, Inc. | PACHECO, ALEXIS BOATENG | 2859 | §102§103 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18562952 | AN UNDERWATER PROBE OR SUBMERSIBLE | UAM Tec Pty Ltd | VASUDEVA, AJAY | 3615 | §102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18248392 | COLLAGEN BIOMATERIAL | Hide Biotech Ltd. | BREEN, KIMBERLY CATHERINE | 1657 | §103§112DP | Final Rejection | — | Pending | Apr 10, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial81.9% of resolved applications prosecuted by Vos-Ip, LLC were allowed, across 329 applications in USPTO records.
3.39 office actions per allowed application on average.
6 pending office actions as of November 2026, for 5 clients, before 6 examiners in 6 art units.